Ukraine To Buy 2 Million Doses Of China's CoronaVac Vaccine
Sinovac Biotech, one of China's leading vaccine producers, developed CoronaVac which underwent trials in Brazil, China, Turkey and Indonesia.
Ukraine said Wednesday it agreed to purchase nearly two million doses of the Chinese-developed CoronaVac coronavirus jab, the post-Soviet country's first commercial contract to purchase a vaccine.
Kiev is due to receive its first batch of 700,000 doses within one month after the vaccine is registered either in China or elsewhere, according to a presidency statement.
Sinovac Biotech, one of China's leading vaccine producers, developed CoronaVac which underwent trials in Brazil, China, Turkey and Indonesia.
President Volodymyr Zelensky said in a statement that authorities would soon roll out "a large-scale" vaccination program.
The deal provides for a total of 1,913,316 doses at 504 hryvnia ($18) per dose, which the presidency said would be given free of charge starting with healthcare workers and the most vulnerable.
It added that the authorities were continuing negotiations with other vaccine producers without naming them.
The health ministry said earlier this month it had agreed a delivery of 8 million vaccine doses via Covax, a World Health Organisation mechanism for global vaccine distribution.
The WHO and partners expect to begin Covax delivers in 2021.
Some pro-Moscow politicians in ex-Soviet Ukraine have lobbied for the introduction of the Russian-developed Sputnik V jab.
But health officials in Kiev have so far refused noting that the Sputnik V was registered before completing large-scale trials.
With the population of 42 million, Ukraine has officially recorded just over one million virus infections and 18,324 Covid-19 deaths.
Kiev is due to receive its first batch of 700,000 doses within one month after the vaccine is registered either in China or elsewhere, according to a presidency statement.
Sinovac Biotech, one of China's leading vaccine producers, developed CoronaVac which underwent trials in Brazil, China, Turkey and Indonesia.
President Volodymyr Zelensky said in a statement that authorities would soon roll out "a large-scale" vaccination program.
The deal provides for a total of 1,913,316 doses at 504 hryvnia ($18) per dose, which the presidency said would be given free of charge starting with healthcare workers and the most vulnerable.
It added that the authorities were continuing negotiations with other vaccine producers without naming them.
The health ministry said earlier this month it had agreed a delivery of 8 million vaccine doses via Covax, a World Health Organisation mechanism for global vaccine distribution.
The WHO and partners expect to begin Covax delivers in 2021.
Some pro-Moscow politicians in ex-Soviet Ukraine have lobbied for the introduction of the Russian-developed Sputnik V jab.
But health officials in Kiev have so far refused noting that the Sputnik V was registered before completing large-scale trials.
With the population of 42 million, Ukraine has officially recorded just over one million virus infections and 18,324 Covid-19 deaths.
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
